Our mission in four pillars

To achieve and maintain the highest level of EU pandemic readiness through the establishment
of a consortium enabling research and development of safe
and effective vaccines and monoclonal antibodies.

Highlights from EVH

Stay informed about key developments, scientific breakthroughs, partnerships, and policy updates related to pandemic vaccine preparedness across Europe.

EVH receives STEP Seal by the European Commission

EVH receives STEP Seal by the European Commission

The European Commission has officially awarded the STEP Seal label to EVH. The Strategic Technologies for Europe Platform (STEP) Seal was set up by the EU to support the European industry and boost i [...]

EVH at the HERA Industry Days!

EVH at the HERA Industry Days!

The European Vaccine Hub (EVH) was presented at the HERA Industry Days in Brussels on June 2nd and 3rd, 2025 (more information here). During the Plenary Panel discussion on Shaping the Future of Vacci [...]

The EVH Kick-off Meeting in Siena, Italy

The EVH Kick-off Meeting in Siena, Italy

The EVH Kick-off Meeting successfully brought together over 160 participants at the Rectorate of the University of Siena, Italy, on May 22–23, 2025. The event gathered representatives from all insti [...]

Launch of the European Vaccines Hub (EVH) for Pandemic Readiness

Launch of the European Vaccines Hub (EVH) for Pandemic Readiness

We are pleased to announce a transformative step in public health as the Health Emergency Preparedness and Response Authority of the European Commission, through the European Health and Digital Execut [...]

Explore European Vaccines Hub

Discover EVH - its mission, structure, and strategic goals to strengthen pandemic preparedness through innovation and scientific excellence.

European Vaccines Hub
European Vaccines Hub
European Vaccines Hub
European Vaccines Hub

Working together for Europe's Vaccine future

The European Vaccine Hub (EVH) unites leading experts, institutions, and innovators to boost pandemic vaccine preparedness across Europe through collaboration, research, and shared solutions.

  • Multinational scientific collaboration
  • Focus on pandemic vaccine readiness
  • Support for policy and regulation
  • Scalable manufacturing and supply networks

Topic

EU4H-2024-PJ-01-1

Total project cost

€169.992.330
(EC contribution: €101.995.398)

Duration

4 years
(1st March 2025-28th February 2029)

Coordinator Entity

Sclavo Vaccines Association (IT)

Appointments & Events

Join relevant upcoming conferences, workshops and key gatherings across Europe.

Vaccine development for BSL-4 viruses

Vaccine development for BSL-4 viruses

As part of the Virology Seminar Series organized by Marburg University, a seminar on breakthroughs in BSL-4 vaccine development was held on 11 November 2025. | Download  | ...

Refining the regulatory context of controlled human infection models

Refining the regulatory context of controlled human infection models

This workshop will convene leading researchers, industry experts, regulators, and ethicists to examine the evolving regulatory, ethical, and scientific landscape of Controlled Human Infection Models (...

EVH Kick-off meeting

EVH Kick-off meeting

The EVH Kick-off Meeting successfully brought together over 160 participants at the Rectorate of the University of Siena, Italy, on May 22–23, 2025. The event gathered representatives from all insti...